Chapter 3 - Emissions guidance - Northern Ireland

AI Summary

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued critical guidance regarding the notification process for e-cigarette and vape products specifically for the Northern Ireland market. Under the Tobacco and Related Products Regulations 2016 (TRPR), manufacturers and importers must adhere to strict transparency requirements before placing products on the market. Although this guidance is not directed at a single company or resulting from a specific inspection date, it addresses systemic issues regarding incomplete emission reporting in the industry. The main regulatory violations typically involve the failure to disclose harmful chemical constituents produced during vaporization. The MHRA explicitly requires the reporting of specific emissions, including Carbon Monoxide, various Carbonyls like formaldehyde, and heavy metals such as nickel and lead. Required actions for businesses include performing standardized laboratory testing and submitting detailed toxicological data through the MHRA notification portal. This ensures that all nicotine-containing products meet established safety standards. By mandating these disclosures, the regulatory framework aims to mitigate health risks and ensure that only compliant products reach consumers in Northern Ireland. Manufacturers must ensure their technical dossiers are complete to avoid delays or market withdrawal actions.